Ovid Therapeutics

Ovid Therapeutics

Ovid Therapeutics

Our mission is to provide innovative medicines to children and adults with neurological disorders.
Type
B2c
Raised
$181M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$75,000,000
IPO - 2017
$25,860,000
Venture capital (Series C) - 2017
Team Size
1–10
Employees
Xconomy

With “Inflection Year” Ahead, Ovid Adds Novartis’s Tardio to C-Suite

$75,000,000 IPO
Xconomy

With $75M Haul, Ovid Continues Flurry of Biotech IPOs

Health Science
$75,000,000 Venture capital (Series B)
Xconomy

Ex-Teva CEO's Brain Disease Startup, Ovid, Bags $75M From Crossovers

Health Funding